Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares RepurchasedShort-Term Debt repayments
Ratios

United Therapeutics (UTHR) Shares Issued (2016 - 2025)

Historic Shares Issued for United Therapeutics (UTHR) over the last 17 years, with Q3 2025 value amounting to $40.2 million.

  • United Therapeutics' Shares Issued rose 2369.23% to $40.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $100.6 million, marking a year-over-year decrease of 2498.14%. This contributed to the annual value of $152.5 million for FY2024, which is 5561.22% up from last year.
  • United Therapeutics' Shares Issued amounted to $40.2 million in Q3 2025, which was up 2369.23% from $18.1 million recorded in Q2 2025.
  • In the past 5 years, United Therapeutics' Shares Issued registered a high of $61.4 million during Q1 2023, and its lowest value of $4.3 million during Q1 2022.
  • For the 5-year period, United Therapeutics' Shares Issued averaged around $24.4 million, with its median value being $18.1 million (2025).
  • Data for United Therapeutics' Shares Issued shows a peak YoY increase of 132790.7% (in 2023) and a maximum YoY decrease of 8684.68% (in 2023) over the last 5 years.
  • Over the past 5 years, United Therapeutics' Shares Issued (Quarter) stood at $7.7 million in 2021, then surged by 620.78% to $55.5 million in 2022, then tumbled by 86.85% to $7.3 million in 2023, then skyrocketed by 252.05% to $25.7 million in 2024, then surged by 56.42% to $40.2 million in 2025.
  • Its Shares Issued stands at $40.2 million for Q3 2025, versus $18.1 million for Q2 2025 and $16.6 million for Q1 2025.